Showing 31,181 - 31,200 results of 106,247 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( e ((non decrease) OR (point decrease)) ))', query time: 1.77s Refine Results
  1. 31181

    Data_Sheet_1_Unequal Impact of COVID-19 on Private and Academic Neurosurgical Workforce: Results of an International Survey.PDF by Sami Ridwan (11510080)

    Published 2021
    “…While 65.7% of participants thought their institutions were adequately prepared, lack of testing for SARS-CoV-2, and scarcity of personal protective equipment were still a matter of concern for most of them. …”
  2. 31182
  3. 31183
  4. 31184
  5. 31185
  6. 31186

    Image_5_The Protective Effects of PSM-04 Against Beta Amyloid-Induced Neurotoxicity in Primary Cortical Neurons and an Animal Model of Alzheimer’s Disease.tiff by Hyunjun Park (650105)

    Published 2019
    “…PSM-04 also decreased oxidative stress induced by H<sub>2</sub>O<sub>2</sub> and apoptotic cell death induced by oligomeric Aβ. …”
  7. 31187

    DataSheet_1_Regulation of X-Ray Irradiation on the Activity and Expression Levels of CYP1A2 and CYP2E1 in Rats.pdf by Xiang-Yang Li (829937)

    Published 2020
    “…Enzyme-linked immunosorbent assay (ELISA) and real-time polymerase chain reaction (PCR) tests were used to analyze the protein and mRNA expression levels of CYP1A2 and CYP2E1, respectively. The AUC<sub>0-12</sub> of caffeine was decreased by 1.7- and 2.5-fold, and the CL was increased by 1.8- and 2.6-fold in the 1 Gy and 5 Gy groups, respectively, compared to the 0 Gy group. …”
  8. 31188
  9. 31189
  10. 31190
  11. 31191

    Shape Stability of Octahedral PtNi Nanocatalysts for Electrochemical Oxygen Reduction Reaction Studied by <i>in situ</i> Transmission Electron Microscopy by Martin Gocyla (1486810)

    Published 2018
    “…Here, we perform <i>in situ</i> heating of compositionally segregated PtNi<sub>1.5</sub> octahedral nanoparticles inside a transmission electron microscope, in order to study their compositional and morphological changes. …”
  12. 31192

    Shape Stability of Octahedral PtNi Nanocatalysts for Electrochemical Oxygen Reduction Reaction Studied by <i>in situ</i> Transmission Electron Microscopy by Martin Gocyla (1486810)

    Published 2018
    “…Here, we perform <i>in situ</i> heating of compositionally segregated PtNi<sub>1.5</sub> octahedral nanoparticles inside a transmission electron microscope, in order to study their compositional and morphological changes. …”
  13. 31193

    Table_1_Case report: One pediatric liver-transplant recipient with SARS-CoV-2 infection suffering unexplained mixed acidosis.pdf by Lianhu Yu (14326539)

    Published 2023
    “…Considering that immunosuppressants may cause metabolic acidosis, dose of CsA was decreased and MMF was discontinued.</p>Results<p>However, liquid replacement therapy and decreased CsA dose cannot improve the condition. …”
  14. 31194
  15. 31195

    Protein Quality Control Disruption by PKCβII in Heart Failure; Rescue by the Selective PKCβII Inhibitor, βIIV5-3 by Julio C. B. Ferreira (145311)

    Published 2012
    “…Importantly, inhibition of PKCβII, using a selective PKCβII peptide inhibitor (βIIV5-3), improved proteasomal activity and conferred protection in cultured neonatal cardiomyocytes. …”
  16. 31196

    Data_Sheet_1_Map2k5-Deficient Mice Manifest Phenotypes and Pathological Changes of Dopamine Deficiency in the Central Nervous System.ZIP by Yumeng Huang (591166)

    Published 2021
    “…Furthermore, Map2k5 mutant mice showed a decreased dopaminergic cell survival and tyrosine hydroxylase levels in nigrostriatal pathway, indicating a crucial role of MAP2K5 in regulating dopamine system in the central nervous system. …”
  17. 31197

    Image_3_Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling.TIF by Jui-Ling Hsu (515080)

    Published 2020
    “…Sildenafil, a specific phosphodiesterase type 5 (PDE5) inhibitor, has been suggested to display both cardioprotective and neuroprotective activities that provide a rationale for the combination with vincristine on the treatment against castration-resistant prostate cancer (CRPC). …”
  18. 31198

    Image_2_Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling.TIF by Jui-Ling Hsu (515080)

    Published 2020
    “…Sildenafil, a specific phosphodiesterase type 5 (PDE5) inhibitor, has been suggested to display both cardioprotective and neuroprotective activities that provide a rationale for the combination with vincristine on the treatment against castration-resistant prostate cancer (CRPC). …”
  19. 31199

    Image_4_Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling.TIF by Jui-Ling Hsu (515080)

    Published 2020
    “…Sildenafil, a specific phosphodiesterase type 5 (PDE5) inhibitor, has been suggested to display both cardioprotective and neuroprotective activities that provide a rationale for the combination with vincristine on the treatment against castration-resistant prostate cancer (CRPC). …”
  20. 31200

    Image_1_Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling.TIF by Jui-Ling Hsu (515080)

    Published 2020
    “…Sildenafil, a specific phosphodiesterase type 5 (PDE5) inhibitor, has been suggested to display both cardioprotective and neuroprotective activities that provide a rationale for the combination with vincristine on the treatment against castration-resistant prostate cancer (CRPC). …”